Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Finel

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 13, 2013
The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidationMartin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 15, 2011
Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissuesMichael H Court, Xiuling Zhang, Xinxin Ding, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2008
Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomesSanna Kaivosaari, Päivi Toivonen, Olli Aitio, et al.
Steroids|December 19, 2006
Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10Athena Starlard-Davenport, Yan Xiong, Stacie Bratton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferasesNenad Manevski, Mika Kurkela, Camilla Höglund, et al.
Data in Brief|February 12, 2019
Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modelingDarja Gramec Skledar, Jurij Trontelj, Johanna Troberg, et al.
Basic & Clinical Pharmacology & Toxicology|April 26, 2024
Anthraquinone biocolourant dermocybin is metabolized whereas dermorubin is not in in vitro liver fractions and recombinant metabolic enzymesJohanna Yli-Öyrä, Risto O Juvonen, Marko Lehtonen, et al.
Chemmedchem|May 8, 2007
Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifololIngo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Journal of Lipid Research|July 3, 2004
Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferasesJoanna M Little, Mika Kurkela, Julia Sonka, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 13, 2013
The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidationMartin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 15, 2011
Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissuesMichael H Court, Xiuling Zhang, Xinxin Ding, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2008
Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomesSanna Kaivosaari, Päivi Toivonen, Olli Aitio, et al.
Steroids|December 19, 2006
Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10Athena Starlard-Davenport, Yan Xiong, Stacie Bratton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferasesNenad Manevski, Mika Kurkela, Camilla Höglund, et al.
Data in Brief|February 12, 2019
Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modelingDarja Gramec Skledar, Jurij Trontelj, Johanna Troberg, et al.
Basic & Clinical Pharmacology & Toxicology|April 26, 2024
Anthraquinone biocolourant dermocybin is metabolized whereas dermorubin is not in in vitro liver fractions and recombinant metabolic enzymesJohanna Yli-Öyrä, Risto O Juvonen, Marko Lehtonen, et al.
Chemmedchem|May 8, 2007
Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifololIngo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Journal of Lipid Research|July 3, 2004
Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferasesJoanna M Little, Mika Kurkela, Julia Sonka, et al.
Pageof 13